Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta‐analysis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Hepatology

• Publication date

  2016-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.28278PMID 26566163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B

  2016cited by this paper
• How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature.

  2014cited by this paper
• Efficacy and Safety of Long-term Adefovir Dipivoxil Therapy in Children With Chronic Hepatitis B Infection

  2012cited by this paper
• Randomized, placebo‐controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

  2012cited by this paper
• Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

  2011cited by this paper
• Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  2010influential reference
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B

  2008cited by this paper
• Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F.

  2007cited by this paper
• Long‐term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety

  2007influential reference
• Long‐term lamivudine therapy for children with HBeAg‐positive chronic hepatitis B

  2006cited by this paper
• [Long-term history of chronic hepatitis B virus infection in children].

  2004influential reference
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Clinical trial of lamivudine in children with chronic hepatitis B.

  2002influential reference
• Impact of chronic hepatitis B and interferon-alpha therapy on growth of children.

  2001cited by this paper
• Impact of chronic hepatitis B and interferon‐α therapy on growth of children

  2001cited by this paper
• Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period.

  1998influential reference
• Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

  1998influential reference
• Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.

  1996influential reference
• Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: A multicenter controlled trial

  1996influential reference
• Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.

  1994influential reference
• Recombinant interferon‐α2a hastens the rate of HBeAg clearance in children with chronic hepatitis B

  1994cited by this paper
• Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.

  1991cited by this paper
• Does hepatitis B virus play a role in primary liver cancer in children of Western countries?

  1991influential reference
• HBV-DNA-related hepatocellular carcinoma occurring in childhood report of three cases

  1991cited by this paper
• Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study.

  1991influential reference
• Prospective, randomized controlled trial of interferon‐α in children with chronic hepatitis B

  1991cited by this paper
• A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.

  1990cited by this paper
• Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood.

  1990cited by this paper
• Childhood primary hepatocellular carcinoma and hepatitis B virus infection

  1990influential reference
• A longitudinal follow‐up of asymptomatic hepatitis B surface antigen‐positive chinese children

  1988cited by this paper
• Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis.

  1987influential reference
• Primary hepatocellular carcinoma with hepatitis B virus-DNA integration in a 4-year-old boy.

  1986influential reference
• Liver cirrhosis associated with chronic hepatitis B virus infection in childhood.

  1986influential reference
• Meta-analysis in clinical trials.

  1986cited by this paper
• Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.

  1985cited by this paper

• Research Progress on the Etiology of Cholestatic Liver Disease in School-Age Children

  2025cites this paper
• Entecavir for children and adults with chronic hepatitis B.

  2025cites this paper
• Trajectories of serum HBsAg during treatment and association with HBsAg loss in children with HBeAg-positive chronic hepatitis B: a latent class trajectory analysis.

  2024cites this paper
• Canadian Association for the Study of the Liver Single Topic Conference on Hepatitis B Virus: 'Progress toward hepatitis B elimination in Canada'.

  2024cites this paper
• Achieving chronic hepatitis B functional cure: Factors and potential mechanisms

  2024cites this paper
• Age at treatment initiation predicts response in children with chronic hepatitis B

  2023cites this paper
• HBV and HCV Infection in Children and Adolescents

  2023cites this paper
• Frequent alanine aminotransferase flares and promising antiviral therapy efficacy during the preschool age: An opportunity to achieve HBsAg loss in children with mother‐to‐child transmitted hepatitis B

  2022cites this paper
• Etiology in Children Presented With Chronic Liver Disease in a Tertiary Care Hospital

  2022cites this paper
• Clinical Predictors of Functional Cure in Children 1–6 Years-old with Chronic Hepatitis B

  2022cites this paper
• Pregnancy and Hepatitis B Immunization: A Commentary on Maternal Knowledge and Vertical Transmission Risks

  2021cites this paper
• Incidence and Predictors of Relapse After Stopping Antiviral Therapy in Pediatric Chronic Hepatitis B

  2021cites this paper
• Natural History of Chronic Hepatitis B Infection Among Chinese Children and Young Adults: A Single-Center Experience

  2021cites this paper
• S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)

  2021cites this paper
• Chronic Hepatitis Is Common and Often Untreated Among Children With Hepatitis B Infection in the United States and Canada.

  2021cites this paper
• Guidelines for Prevention and Treatment of Chronic Hepatitis B

  2021cites this paper
• Viral Hepatitis B—Management in Children

  2021cites this paper
• Treatment of hepatitis B virus infection in children and adolescents

  2021cites this paper
• Tenofovir Disoproxil Fumarate in the Management of Chronic Hepatitis B Infection in Children

  2021cites this paper
• Leitlinienreport zur aktualisierten S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion

  2021cites this paper
• On-treatment HBV RNA Dynamic Predicts Entecavir-induced HBeAg Seroconversion in Children with Chronic Hepatitis B: HBV RNA predicts HBeAg seroconversion.

  2021cites this paper
• Hepatitis

  2020cites this paper
• Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020).

  2020cites this paper
• Specific Medications for Chronic Viral Hepatitis

  2020cites this paper
• Chronic viral hepatitis B in children and adolescents: a modern view of the problem

  2020cites this paper
• Treatment of hepatitis B in children

  2020cites this paper
• Major Advances in Hepatitis C Treatment but Not Hepatitis B

  2020cites this paper
• Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark – a region wide study

  2020cites this paper
• Spontaneous loss of chronic HBV infection markers in treatment-naïve children: a systematic review and pooled meta-analyses

  2020cites this paper
• Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)

  2020cites this paper
• Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children.

  2020cites this paper
• Pharmacotherapy options for managing hepatitis B in children

  2020cites this paper
• Chronic Viral Hepatitis

  2019cites this paper
• Hepatitis B Virus Infection and the Progress toward its Elimination

  2019cites this paper
• Taiwan consensus statement on the management of chronic hepatitis B.

  2019cites this paper
• Glomerular Diseases Associated with Hepatitis B and C Infection, Pediatric

  2019cites this paper
• The butterfly effect in viral infection: From a host DNA single nucleotide change to HBV episome steadiness

  2019cites this paper
• Hepatitis B virus infection in children and adolescents.

  2019cites this paper
• Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B.

  2019cites this paper
• A Functional Variant in Ubiquitin Conjugating Enzyme E2 L3 Contributes to Hepatitis B Virus Infection and Maintains Covalently Closed Circular DNA Stability by Inducing Degradation of Apolipoprotein B mRNA Editing Enzyme Catalytic Subunit 3A

  2019cites this paper
• Lamivudine therapy for chronic hepatitis B in children: a meta-analysis

  2019cites this paper
• Viral Hepatitis B: Management in Children

  2019cites this paper
• A functional variant in UBE 2 L 3 contributes to HBV infection and maintains cccDNA stability by inducing degradation of APOBEC 3 A protein

  2019cites this paper
• Treatment of infants with hepatitis B virus: A window of opportunity?

  2019cites this paper
• Updates in the management of hepatitis B in children

  2019cites this paper
• Meta-analyses frequently pooled different study types together: a meta-epidemiological study.

  2019cites this paper
• Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy.

  2019cites this paper
• Sexually Transmitted Diseases in Children and Adolescents

  2019cites this paper
• The management of hepatitis B and hepatitis C in children.

  2018cites this paper
• Hepatitis B and C.

  2018cites this paper
• Global HBV burden: guesstimates and facts

  2018cites this paper
• Editorial: an expert consensus for the management of chronic hepatitis B in Asian Americans

  2018cites this paper
• Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

  2018cites this paper
• Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance

  2018cites this paper
• Hepatitis bei Kindern und Jugendlichen

  2018cites this paper
• Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.

  2018cites this paper
• Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices

  2018cites this paper
• Paediatric chronic hepatitis B virus infection: are children too tolerant to treat?

  2018cites this paper
• Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission

  2017cites this paper
• Guidelines on the management of hepatitis B virus infection q European Association for the Study of the Liver

  2017cites this paper
• Co-infections of hepatitis B patients with other hepatitis viruses and their serological, biological and prognostic markers

  2017cites this paper
• Decreased Expression Levels of S100A12 and RAGE May Be Associated with Chronic HBV Infection

  2017cites this paper
• Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis

  2017cites this paper
• EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

  2017cites this paper
• INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.

  2017cites this paper
• Treatment of chronic hepatitis B infection‐2017

  2017cites this paper
• Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment

  2017cites this paper
• Clinical Practice Guidelines EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection q European Association for the Study of the Liver

  2017cites this paper
• Recommendations for the treatment of hepatitis B in 2017

  2017cites this paper
• Current treatments for chronic hepatitis B virus infections.

  2016cites this paper
• PEDIATRIC CHRONIC VIRAL HEPATITIS – THERAPEUTIC CONSIDERATIONS

  2016cites this paper
• AASLD guidelines for treatment of chronic hepatitis B

  2016cites this paper
• AASLD practice guidelines: The past, the present, and the future

  2016cites this paper
• Innate responses CD 8 + cells B cells CD 4 + cells Adaptive immune responses Interferon alpha hNTCP Nucleos ( t ) ide analogues

  2016cites this paper
• Guidelines for Treatment of Chronic Hepatitis B

  2015cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper